Legacy Health Capital

The firm pursues both control buyout transactions and minority growth investments in US healthcare services and digital health companies. Its documented focus areas include physician practice management, specialty pharmacy, and ambulatory surgery centers, with a preference for founder-owned businesses where operational improvement can drive value. Deal structures include platform acquisitions designed for add-on consolidation and structured growth equity rounds.

Given its specialized healthcare mandate and operational capabilities, Legacy Health Capital likely sources through a combination of proprietary origination networks — including relationships with hospital systems, physician groups, and healthcare intermediaries — alongside traditional intermediated processes. The firm's separate operations entity (veloxoperations.com) suggests it can approach targets with a pre-built operational solution, which strengthens direct outreach to founder-owned practices considering a transition.

Legacy Health Capital participates in both majority buyouts and minority growth investments. Control transactions are typically structured around founder-owned healthcare businesses seeking an operational partner; minority investments target companies scaling technology or care delivery models where existing management retains day-to-day control.

The firm invests primarily across the United States, with a documented emphasis on healthcare businesses in the Western and Southeastern regions. These geographies offer favorable unit economics and demographic tailwinds — including aging populations and physician practice consolidation trends — that align with the firm's buy-and-build strategy.

Legacy Health Capital maintains a separate operations platform under the veloxoperations.com domain, an architecture that suggests an affiliated operating company handles shared back-office functions, clinical optimization, and compliance infrastructure for portfolio companies. This integrated model is designed to address the primary execution risks in healthcare private equity — particularly payer contracting, credentialing, and regulatory compliance — that often challenge generalist investors.